首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1904319

胰島素筆市場規模、佔有率及成長分析（按類型、應用和地區分類）－2026-2033年產業預測

Insulin Pens Market Size, Share, and Growth Analysis, By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，胰島素筆市場規模將達到 13.1 億美元，到 2025 年將達到 13.9 億美元，到 2033 年將達到 22.6 億美元，在預測期（2026-2033 年）內，複合年成長率為 6.26%。

全球胰島素筆市場正經歷強勁成長，這主要得益於糖尿病患者數量的不斷增加以及他們對胰島素筆這種便捷易用的給藥方式日益成長的偏好。胰島素筆因其易用性、劑量精準和便攜性而廣受糖尿病患者的歡迎。糖尿病患者數量的成長，尤其是在開發中國家，以及人們對胰島素給藥益處的認知不斷提高，都推動了這個市場的擴張。記憶功能和藍牙連接等技術創新正在提升胰島素筆的易用性和改善患者的治療效果。然而，高成本的成本，尤其是高階型號的價格，阻礙了胰島素筆在低收入地區的廣泛應用。此外，醫療基礎設施的匱乏和嚴格的監管要求也構成了進一步的障礙，迫使製造商在研發和合規方面投入大量資金。

胰島素筆市場成長要素

胰島素筆市場的成長主要得益於此類設備技術的不斷創新。藍牙連結、記憶功能以及智慧胰島素筆的出現等特性，正在提升患者的整體體驗，進而改善治療效果。這些進步不僅為使用者帶來便利和實用功能，還有助於更好地管理糖尿病。這些先進工具的日益普及，推動了病患和醫療服務提供者的需求，進而帶動了胰島素筆的市場需求。這一趨勢凸顯了科技在變革糖尿病管理解決方案方面所扮演的重要角色。

胰島素筆市場的限制因素

由於部分族群對針頭和自行注射存在恐懼，胰島素筆市場面臨一些挑戰。這種恐懼通常被稱為針頭恐懼症，會阻礙胰島素筆的接受度和規律使用，導致患者因不願意自行注射而猶豫不決。因此，許多患者可能會尋求替代方案。這種不願意自行注射的心理會對治療依從性和整體糖尿病管理產生重大影響，使其成為胰島素筆市場成長的一個顯著阻礙因素。

胰島素筆市場趨勢

胰島素筆市場正呈現出顯著的客製化和個人化趨勢，反映出消費者期望的不斷變化，他們希望獲得能夠滿足自身個人化需求和偏好的產品。製造商正日益為用戶提供多種選擇，包括不同的顏色、劑量設置，甚至是個人化的品牌元素。這一趨勢不僅提升了用戶參與度，也提高了患者滿意度，因為客製化的解決方案能夠更有效地管理糖尿病。因此，可客製化胰島素筆的廣泛應用有望推動市場成長，增強患者與其血糖管理工具之間的聯繫，並最終有助於改善患者的健康狀況。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Ypsomed Holding AG
BD（Becton, Dickinson and Company）
Owen Mumford Ltd
Haselmeier AG
Medtronic plc
Emperra GmbH E-Health Technologies
Diamesco Co., Ltd.
MANNKind Corporation
Jiangsu Delfu Medical Device Co., Ltd.
Pendiq GmbH
Sensile Medical AG
Injex Pharma AG
Copernicus Sp. z oo
Wockhardt Ltd

結論與建議

簡介目錄

Product Code: SQMIG35B2138

Insulin Pens Market size was valued at USD 1.31 Billion in 2024 and is poised to grow from USD 1.39 Billion in 2025 to USD 2.26 Billion by 2033, growing at a CAGR of 6.26% during the forecast period (2026-2033).

The global insulin pens market is experiencing robust growth, driven by the rising prevalence of diabetes and the increasing preference for insulin pens as a convenient, user-friendly delivery method. These pens are favored for their ease of use, accurate dosing, and portability, particularly among diabetic patients. The expanding diabetic population, especially in developing nations, along with heightened awareness of insulin delivery benefits fuels this market expansion. Technological innovations, such as memory functions and Bluetooth connectivity, have enhanced usability and patient outcomes. However, challenges such as high costs, especially for advanced models, hinder affordability in low-income areas. Additionally, limited healthcare infrastructure and stringent regulatory requirements pose further obstacles, necessitating significant investments in research, development, and compliance for manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Insulin Pens Market Segments Analysis

Global Insulin Pens Market is segmented by Type, End-use, and region. Based on Type, the market is segmented into Reusable Insulin Pens, and Disposable Insulin Pens. Based on End-use, the market is segmented into Hospitals & Clinics, Homecare, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Insulin Pens Market

The growth of the insulin pens market is significantly fueled by ongoing technological innovations in these devices. Features such as Bluetooth connectivity, memory capabilities, and the emergence of smart insulin pens are enhancing the overall patient experience and leading to improved treatment outcomes. These advancements not only provide users with added convenience and functionality but also promote better management of diabetes. As these sophisticated tools become increasingly available, their appeal expands among patients and healthcare providers alike, ultimately driving the demand for insulin pens in the market. This trend highlights the importance of technology in transforming diabetes management solutions.

Restraints in the Insulin Pens Market

The Insulin Pens market faces certain challenges due to the apprehension some individuals have towards needles and self-injection. This fear, often termed needle phobia, can hinder acceptance and regular usage of insulin pens, leading to reluctance among patients who are uncomfortable with the idea of injecting themselves. As a result, many may seek alternative methods for insulin delivery that they perceive as less intimidating or more user-friendly. This resistance to self-injection can significantly impact treatment adherence and overall management of diabetes, thereby presenting a noteworthy constraint on the growth of the insulin pen market.

Market Trends of the Insulin Pens Market

The insulin pens market is witnessing a notable trend towards customization and personalization, reflecting a shift in consumer expectations for products that align with individual needs and preferences. Manufacturers are increasingly offering options that allow users to select from various colors, dose settings, and even personalized branding elements. This trend not only enhances user engagement but also drives patient satisfaction, as tailored solutions empower individuals to manage their diabetes more effectively. As a result, the proliferation of customizable insulin pens is expected to bolster market growth and foster a stronger connection between patients and their management tools, ultimately improving health outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies
Customer & Buying Criteria Analysis

Global Insulin Pens Market Size by Type & CAGR (2026-2033)

Market Overview
Reusable Insulin Pens
Disposable Insulin Pens

Global Insulin Pens Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Homecare
Others

Global Insulin Pens Market Size & CAGR (2026-2033)

North America, (Type, End-use)
- US
- Canada
Europe, (Type, End-use)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Type, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Type, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa, (Type, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haselmeier AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diamesco Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MANNKind Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Medical Device Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pendiq GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sensile Medical AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Injex Pharma AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Copernicus Sp. z o.o.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments